comparemela.com

Latest Breaking News On - Hong kong association of the pharmaceutical industry - Page 1 : comparemela.com

Hong Kong s Hospital Authority pledges to reduce ethics review process on clinical trials from 6 months to 30 days starting next year

Opinion: Hong Kong has what it takes to be a medical hub

City has the expertise – and connections with mainland China – to be a serious and world-leading player in the biomedical industry.

John Lee policy address 2023: Hong Kong banks on cross-border collaboration to boost medical innovation hub ambitions

Hong Kong patients could have quicker access to new drugs if authorities streamline certification process, experts say

Gibson Dunn | Five Years of Antitrust Enforcement in Hong Kong

December 22, 2020 The substantive provisions of Hong Kong’s Competition Ordinance (“Ordinance”) came into force in December 2015. This note looks at the main achievements in the first five years and some of the challenges laying ahead. The main achievements of the Hong Kong Competition Commission (“Commission”) are first and foremost building up from scratch a competent and trustworthy institution. The Commission has hired seasoned enforcers from overseas with impeccable reputations which has brought immediate credibility to the Commission. It has embarked on a wide range of educational activities, including seminars, advertising and publishing guidelines detailing its enforcement priorities and interpretation of the Ordinance. The Commission has also adopted a world-class leniency programme to facilitate the prosecution of cartels, its main priority. The Commission proceeded to win its first case in court thereby confirming that it is a force to be reckoned with.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.